Lunit, a leading provider of artificial intelligence solutions for cancer diagnostics and therapeutics, has announced a strategic collaboration with Microsoft aimed at expanding the global reach and clinical utility of AI in oncology. The partnership also builds upon Lunit’s recent acquisition of Volpara, a Microsoft Industry Health Certified Partner, reinforcing the alliance's technical and regulatory alignment.
At the heart of the collaboration is a commitment to develop scalable, integrated AI healthcare solutions on Microsoft Azure. A key component will be the co-development of a model customization service that allows individual healthcare providers to fine-tune AI models using their own site-specific clinical data. This capability is designed to tackle one of the most persistent challenges in AI deployment in healthcare: the variability of model performance across different institutions. By enabling localized adaptation of diagnostic models, the solution aims to deliver more consistent and clinically relevant results.
In addition, Lunit will harness Microsoft’s agentic AI frameworks to move beyond standalone tools and develop automated, intelligent workflows. These solutions are expected to enhance decision-making and streamline operations, offering providers a more holistic approach to patient care. The automation of end-to-end processes is particularly critical in environments where clinicians face increasing demands on time and resources.
“For AI to truly make an impact in healthcare, it must be accessible, scalable, and seamlessly integrated into clinical practice,” said Brandon Suh, CEO of Lunit. He further emphasized, “Our collaboration with Microsoft enables us to bring our AI to more providers through trusted platforms like Microsoft Azure, helping us expand access in the U.S. and beyond. This collaboration brings us one step closer to delivering high-quality, consistent care through AI—at scale.”
The partnership reflects a broader trend toward embedding AI into existing health IT infrastructures, positioning AI not as a standalone diagnostic aid but as an embedded, adaptive engine for system-wide clinical improvement.
Click here for the original news story.